About Drupal 8
Have you ever felt that your website needs to be more personalized, integrated with cutting-edge technology to offer enhanced user experience?
Valuebound is one of those companies, which specifically help organizations in their path to digital transformation. We enhance digital experience for end users with tailored web applications.
Recent releases
|
Developing Custom Drupal Modules Using Object-Oriented Programming
Learn the benefits and best practices of using object-oriented programming to develop custom Drupal modules. Improve code maintainability, scalability, and reusability with practical examples and…
|
How to Add Dependency Injection in a Controller in Drupal 9
Delve into the intricacies of dependency injection in Drupal 9, demonstrating through practical examples the creation of services and their invocation via dependency injection within a controller.
|
How to Conduct a Drupal Security Audit: Summary of Modules and Libraries
Improve the security of your application by checking and auditing Drupal modules, PHP and JavaScript libraries. Get assistance from Drupal experts at Valuebound in performing a thorough security…
|
WhatsApp integration in Web Applications
Discover how integrating WhatsApp into your web application can enhance communication with your customers and improve their overall experience.
CASE STUDY
See all our work
How a Top Indian Pharma Brand Boosted HCP Engagement Using Tech-Led Omnichannel Marketing
India’s renowned pharmaceutical company, known for its strong presence in chronic therapy areas, was facing a growing disconnect with its most important audience: healthcare professionals.
How a Leading Indian Pharma Brand Expanded Reach Across Semi-Urban & Rural Regions
A leading pharmaceutical company in India, well known for its OTC presence and deep connection with mass-market audiences, was preparing to launch a public awareness campaign focused on maternal he
Driving Digital Engagement for a Chronic Care Program with Tech-Led Pharma Marketing
A leading pharmaceutical company in India, known for its chronic care drug portfolio, was preparing to launch a support program aimed at patients diagnosed with congestive heart failure (CHF).
